Report Detail

Other Global Congestive Heart Failure (CHF) Treatment Devices Market Professional Survey Report 2019

  • RnM3780470
  • |
  • 25 September, 2019
  • |
  • Global
  • |
  • 108 Pages
  • |
  • QYResearch
  • |
  • Other

Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
This is primarily attributed to the constantly changing lifestyle habits (such as unhealthy dietary habits, excessive alcohol consumption, smoking, obesity, and lack of physical activity) which make individuals more susceptible to arrhythmia and heart failure. In addition, a number of factors such as the large number of technological advancements in CHF treatment devices, increased adoption rate of these devices, and rising emphasis on early intervention and primary prevention of heart-related disorders are responsible for driving the market. Conversely, stringent government regulations for the approval of CHF treatment devices, high cost of, and high preference to drugs for CHF treatment are some of the factors restraining the market growth.

The global Congestive Heart Failure (CHF) Treatment Devices market was valued at 11000 million US$ in 2018 and will reach 17200 million US$ by the end of 2025, growing at a CAGR of 5.7% during 2019-2025.
This report focuses on Congestive Heart Failure (CHF) Treatment Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Congestive Heart Failure (CHF) Treatment Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Congestive Heart Failure (CHF) Treatment Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Congestive Heart Failure (CHF) Treatment Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abiomed
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
HeartWare International
Jarvik Heart
LivaNova PLC
Medtronic
ReliantHeart
St. Jude Medical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs)

Segment by Application
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)


Table of Contents

    Executive Summary

      1 Industry Overview of Congestive Heart Failure (CHF) Treatment Devices

      • 1.1 Definition of Congestive Heart Failure (CHF) Treatment Devices
      • 1.2 Congestive Heart Failure (CHF) Treatment Devices Segment by Type
        • 1.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Cardiac Resynchronization Therapy (CRT)
        • 1.2.3 Implantable Cardioverter Defibrillators (ICDs)
      • 1.3 Congestive Heart Failure (CHF) Treatment Devices Segment by Applications
        • 1.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Left Ventricular Assist Device (LVAD)
        • 1.3.3 Right Ventricular Assist Device (RVAD)
        • 1.3.4 Biventricular Assist Device (BIVAD)
      • 1.4 Global Congestive Heart Failure (CHF) Treatment Devices Overall Market
        • 1.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue (2014-2025)
        • 1.4.2 Global Congestive Heart Failure (CHF) Treatment Devices Production (2014-2025)
        • 1.4.3 North America Congestive Heart Failure (CHF) Treatment Devices Status and Prospect (2014-2025)
        • 1.4.4 Europe Congestive Heart Failure (CHF) Treatment Devices Status and Prospect (2014-2025)
        • 1.4.5 China Congestive Heart Failure (CHF) Treatment Devices Status and Prospect (2014-2025)
        • 1.4.6 Japan Congestive Heart Failure (CHF) Treatment Devices Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Status and Prospect (2014-2025)
        • 1.4.8 India Congestive Heart Failure (CHF) Treatment Devices Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Congestive Heart Failure (CHF) Treatment Devices
      • 2.3 Manufacturing Process Analysis of Congestive Heart Failure (CHF) Treatment Devices
      • 2.4 Industry Chain Structure of Congestive Heart Failure (CHF) Treatment Devices

      3 Development and Manufacturing Plants Analysis of Congestive Heart Failure (CHF) Treatment Devices

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Congestive Heart Failure (CHF) Treatment Devices Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Congestive Heart Failure (CHF) Treatment Devices
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Congestive Heart Failure (CHF) Treatment Devices Production and Capacity Analysis
      • 4.2 Congestive Heart Failure (CHF) Treatment Devices Revenue Analysis
      • 4.3 Congestive Heart Failure (CHF) Treatment Devices Price Analysis
      • 4.4 Market Concentration Degree

      5 Congestive Heart Failure (CHF) Treatment Devices Regional Market Analysis

      • 5.1 Congestive Heart Failure (CHF) Treatment Devices Production by Regions
        • 5.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Production by Regions
        • 5.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Regions
      • 5.2 Congestive Heart Failure (CHF) Treatment Devices Consumption by Regions
      • 5.3 North America Congestive Heart Failure (CHF) Treatment Devices Market Analysis
        • 5.3.1 North America Congestive Heart Failure (CHF) Treatment Devices Production
        • 5.3.2 North America Congestive Heart Failure (CHF) Treatment Devices Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Congestive Heart Failure (CHF) Treatment Devices Import and Export
      • 5.4 Europe Congestive Heart Failure (CHF) Treatment Devices Market Analysis
        • 5.4.1 Europe Congestive Heart Failure (CHF) Treatment Devices Production
        • 5.4.2 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Congestive Heart Failure (CHF) Treatment Devices Import and Export
      • 5.5 China Congestive Heart Failure (CHF) Treatment Devices Market Analysis
        • 5.5.1 China Congestive Heart Failure (CHF) Treatment Devices Production
        • 5.5.2 China Congestive Heart Failure (CHF) Treatment Devices Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Congestive Heart Failure (CHF) Treatment Devices Import and Export
      • 5.6 Japan Congestive Heart Failure (CHF) Treatment Devices Market Analysis
        • 5.6.1 Japan Congestive Heart Failure (CHF) Treatment Devices Production
        • 5.6.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Congestive Heart Failure (CHF) Treatment Devices Import and Export
      • 5.7 Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Market Analysis
        • 5.7.1 Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Production
        • 5.7.2 Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Import and Export
      • 5.8 India Congestive Heart Failure (CHF) Treatment Devices Market Analysis
        • 5.8.1 India Congestive Heart Failure (CHF) Treatment Devices Production
        • 5.8.2 India Congestive Heart Failure (CHF) Treatment Devices Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Congestive Heart Failure (CHF) Treatment Devices Import and Export

      6 Congestive Heart Failure (CHF) Treatment Devices Segment Market Analysis (by Type)

      • 6.1 Global Congestive Heart Failure (CHF) Treatment Devices Production by Type
      • 6.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type
      • 6.3 Congestive Heart Failure (CHF) Treatment Devices Price by Type

      7 Congestive Heart Failure (CHF) Treatment Devices Segment Market Analysis (by Application)

      • 7.1 Global Congestive Heart Failure (CHF) Treatment Devices Consumption by Application
      • 7.2 Global Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Application (2014-2019)

      8 Congestive Heart Failure (CHF) Treatment Devices Major Manufacturers Analysis

      • 8.1 Abiomed
        • 8.1.1 Abiomed Congestive Heart Failure (CHF) Treatment Devices Production Sites and Area Served
        • 8.1.2 Abiomed Product Introduction, Application and Specification
        • 8.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Berlin Heart GmbH
        • 8.2.1 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Production Sites and Area Served
        • 8.2.2 Berlin Heart GmbH Product Introduction, Application and Specification
        • 8.2.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Biotronik SE & Co. KG
        • 8.3.1 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Production Sites and Area Served
        • 8.3.2 Biotronik SE & Co. KG Product Introduction, Application and Specification
        • 8.3.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Boston Scientific Corporation
        • 8.4.1 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Production Sites and Area Served
        • 8.4.2 Boston Scientific Corporation Product Introduction, Application and Specification
        • 8.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 HeartWare International
        • 8.5.1 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Production Sites and Area Served
        • 8.5.2 HeartWare International Product Introduction, Application and Specification
        • 8.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Jarvik Heart
        • 8.6.1 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Production Sites and Area Served
        • 8.6.2 Jarvik Heart Product Introduction, Application and Specification
        • 8.6.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 LivaNova PLC
        • 8.7.1 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Production Sites and Area Served
        • 8.7.2 LivaNova PLC Product Introduction, Application and Specification
        • 8.7.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Medtronic
        • 8.8.1 Medtronic Congestive Heart Failure (CHF) Treatment Devices Production Sites and Area Served
        • 8.8.2 Medtronic Product Introduction, Application and Specification
        • 8.8.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 ReliantHeart
        • 8.9.1 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Production Sites and Area Served
        • 8.9.2 ReliantHeart Product Introduction, Application and Specification
        • 8.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 St. Jude Medical
        • 8.10.1 St. Jude Medical Congestive Heart Failure (CHF) Treatment Devices Production Sites and Area Served
        • 8.10.2 St. Jude Medical Product Introduction, Application and Specification
        • 8.10.3 St. Jude Medical Congestive Heart Failure (CHF) Treatment Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Congestive Heart Failure (CHF) Treatment Devices Market

      • 9.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Trend Analysis
        • 9.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Congestive Heart Failure (CHF) Treatment Devices Regional Market Trend
        • 9.2.1 North America Congestive Heart Failure (CHF) Treatment Devices Forecast 2019-2025
        • 9.2.2 Europe Congestive Heart Failure (CHF) Treatment Devices Forecast 2019-2025
        • 9.2.3 China Congestive Heart Failure (CHF) Treatment Devices Forecast 2019-2025
        • 9.2.4 Japan Congestive Heart Failure (CHF) Treatment Devices Forecast 2019-2025
        • 9.2.5 Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Forecast 2019-2025
        • 9.2.6 India Congestive Heart Failure (CHF) Treatment Devices Forecast 2019-2025
      • 9.3 Congestive Heart Failure (CHF) Treatment Devices Market Trend (Product Type)
      • 9.4 Congestive Heart Failure (CHF) Treatment Devices Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Congestive Heart Failure (CHF) Treatment Devices Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Congestive Heart Failure (CHF) Treatment Devices. Industry analysis & Market Report on Congestive Heart Failure (CHF) Treatment Devices is a syndicated market report, published as Global Congestive Heart Failure (CHF) Treatment Devices Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Congestive Heart Failure (CHF) Treatment Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,789.50
        4,184.25
        5,579.00
        3,255.00
        4,882.50
        6,510.00
        535,080.00
        802,620.00
        1,070,160.00
        292,005.00
        438,007.50
        584,010.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report